CAS 79515-34-7
:L-Lysinamide,L-tyrosylglycylglycyl-L-phenylalanyl-L-leucyl-L-arginyl-L-arginyl-L-isoleucyl-L-arginyl-L-prolyl-L-lysyl-L-leucyl-
Description:
L-Lysinamide, L-tyrosylglycylglycyl-L-phenylalanyl-L-leucyl-L-arginyl-L-arginyl-L-isoleucyl-L-arginyl-L-prolyl-L-lysyl-L-leucyl- is a complex peptide composed of multiple amino acids, which are the building blocks of proteins. This substance is characterized by its specific sequence of amino acids, which influences its structure and function. Peptides like this one can exhibit various biological activities, including roles in signaling, enzyme activity, and cellular communication. The presence of multiple arginine residues suggests potential interactions with negatively charged molecules, while the inclusion of hydrophobic amino acids like phenylalanine and leucine may influence its solubility and membrane interactions. The CAS number 79515-34-7 identifies this compound uniquely in chemical databases, facilitating research and regulatory processes. Overall, the characteristics of this peptide are determined by its amino acid composition, sequence, and the resulting three-dimensional structure, which ultimately dictate its biological functions and potential applications in fields such as biochemistry and pharmacology.
Formula:C75H127N25O14
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Dynorphin A (1-13) amide
CAS:Antagonist of human MC1, MC3 and MC4 receptors.Formula:C75H127N25O14Purity:97.4%Color and Shape:WhiteMolecular weight:1602.97Dynorphin A (1-13) amide
CAS:Dynorphin A (1-13) amide, an endogenous opioid peptide, counteracts the analgesic effects of morphine [1].Formula:C75H127N25O14Molecular weight:1602.97Dynorphin A (1-13) amide trifluoroacetate salt
CAS:<p>Please enquire for more information about Dynorphin A (1-13) amide trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C75H127N25O14Purity:Min. 95%Molecular weight:1,602.97 g/mol



